AACC 2020 Disruptive Tech Award-Winning Diagnostic Testing Platform Could Detect COVID-19 in 14 Minutes
A COVID-19 test is being developed on a near-patient testing platform that won the Disruptive Technology Award at the 2020 AACC virtual meeting and could perform rapid reverse transcription polymerase chain reaction (RT-PCR) to generate results in as little as 14 minutes. More...17 Dec 2020
FDA Grants EUA to First COVID-19 Test for Non-Prescription Home Use in Symptomatic and Asymptomatic Individuals
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to the a rapid, at-home test for non-prescription home use for the detection of active COVID-19 in individuals with or without symptoms, and in adults and children aged two years and above. More...16 Dec 2020
Eurofins Launches Rapid SARS-CoV-2 Antigen Test and RT-PCR Test in Self-Sampled, Gargling Format
Eurofins Technologies (Budapest, Hungary) has launched a CE-IVD labeled rapid test for the detection of SARS-CoV-2 antigens in 15 minutes and a SARS-CoV-2 RT-PCR test that has been successfully validated for pharynx gargling samples, providing a gold standard PCR test in an easy-to-use, self-sampling format. More...15 Dec 2020
PerkinElmer’s EUROIMMUN Launches New CE Marked PCR Test to Differentiate Between COVID-19 and Flu
EUROIMMUN, a PerkinElmer, Inc. (Waltham, MA; USA) company, has launched the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B. More...15 Dec 2020
First-Ever Artificial Intelligence Software Uses Routine Blood Tests to Help Labs Rule Out COVID-19
Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit to help rule out the possibility of infection from the SARS-CoV-2 virus. More...15 Dec 2020
Self-Collected Saliva Samples as Effective as Nasopharyngeal and Oropharyngeal Swabs for Diagnosing COVID-19, Finds Study
The use of self-collected saliva for diagnosing COVID-19 can minimize healthcare worker exposure and expand testing capabilities for symptomatic and asymptomatic patients, according to a new study. More...15 Dec 2020
In Other News
Smartphone-Read Ultrasensitive and Quantitative Saliva Test for COVID-19 Provides Results within 15 Minutes
FDA Develops Fecal Test for COVID-19
Roche Launches Laboratory SARS-CoV-2 Antigen Test for High-Volume Testing of Suspected COVID-19 Patients
Randox Launches Mobile COVID-19 Lab that Processes 1000 Samples per Day and Generates Results in 1-3 Hours
POC Reader Automatically Analyzes COVID-19 Test Strips and Transmits Results Electronically
Novel Rapid Lateral Flow Immunoassay Can Function as `Suitcase Laboratory` for On-Site Detection of COVID-19
Thermo Fisher’s New Direct from Saliva PCR Test for COVID-19 Enables Fast, Low-Cost Results
Roche Partners with Moderna for Use of Its SARS-CoV-2 Antibody Test in COVID-19 Vaccine Trials
EKF Launches One of the First Tests to Precisely Measure Levels of COVID-19 Neutralizing Antibodies
COVID-19 Test Uses `Lab at Your Fingertip` Technology to Measure SARS-CoV-2 Antibodies in 15 Minutes
COVID-19 Diagnostics Market to Surpass Revenues of USD 13 Billion in 2020
Remarkably Stable Virus-Like Positive Controls for COVID-19 Assays
Ultra-Specific, Non-Invasive Saliva Test Enables Quantitative Testing Of COVID-19 Antibodies
Minimally-Invasive, Point-of-Care Test for COVID-19 Patients Assesses Disease Progression
High-Speed NanoPCR Technology Diagnoses COVID-19 in 20 Minutes with Zero False Positive and False Negative
Rapid, Ultrasensitive Test Uses Paper-Based Electrochemical Sensor to Detect COVID-19 in Five Minutes
New COVID-19 Testing Approach That Measures Immune Response Can Be Combined with Standard PCR Tests for Accurate Diagnosis
New Blood Test for Early Immune Response to SARS-CoV-2 Could Enable Early Detection of Serious COVID-19 Patients
Low-Cost, Easy to Use COVID-19 Saliva Test Provides Accurate Results within 30 Minutes
Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic
QIAGEN Launches QuantiFERON SARS-CoV-2 RUO Solution That Detects T-Cell Response to Novel Coronavirus
FDA Authorizes First COVID-19 and Flu Combination Test for Use with Home-Collected Samples
New CRISPR-Based COVID-19 Test Uses Smartphone Camera to Provide Accurate Results in 30 Minutes